# FDA Inspection 1179634 - GlaxoSmithKline Biologicals - September 13, 2022

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/b7981ae6-29ac-4d33-bb97-b46c00e4538f
Source feed: FDA_Inspections

> FDA Inspection 1179634 for GlaxoSmithKline Biologicals on September 13, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1179634
- Company Name: GlaxoSmithKline Biologicals
- Inspection Date: 2022-09-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1232702 - 2024-03-12](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals/70a6a284-2119-4f02-9b73-85f02c66c432)

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals/98ade6fb-8ae1-48af-a7cf-71b26cd2e808

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d